Safety and Regulatory Status Both BPC-157 and TB-500 remain unapproved for human medical use and are not sanctioned by major drug regulatory agencies for therapeutic applications
Sikiric P, Drmic D, Sever M, et al
Psoriasis clinical trials are designed to gather data and assess the benefits and potential risks of the treatments under investigation and results depend upon individual responses.
Response Variability Individual response to BPC-157 varies based on factors including injury type and severity, individual healing capacity, product quality, protocol compliance, and concurrent lifestyle factors
You may resume most of your daily activities right away
Children under 02 years and 11 months are considered INF (babies), do not pay any service and do not have the right to food, bed or seat on the tours